{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e77afad3",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "b2a8552d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>termination_category</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00025493</td>\n",
       "      <td>S0029 Docetaxel in Treating Older Women With M...</td>\n",
       "      <td>poor accrual</td>\n",
       "      <td>Enrollment</td>\n",
       "      <td>RATIONALE: Drugs used in chemotherapy use diff...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00726986</td>\n",
       "      <td>Sorafenib, Cisplatin, and Etoposide in Treatin...</td>\n",
       "      <td>Extreme toxicity</td>\n",
       "      <td>Safety</td>\n",
       "      <td>RATIONALE: Sorafenib may stop the growth of tu...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04218825</td>\n",
       "      <td>REACH: Study to Determine the Aetiology of Chl...</td>\n",
       "      <td>After an extensive assessment of the study fea...</td>\n",
       "      <td>Enrollment</td>\n",
       "      <td>Adult patients with early stage MF-CTCL (stage...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01548651</td>\n",
       "      <td>Effect of Saxagliptin Treatment on Myocardial ...</td>\n",
       "      <td>difficulty with enrollment of subjects</td>\n",
       "      <td>Enrollment</td>\n",
       "      <td>The purpose of the study is to examine the eff...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00531271</td>\n",
       "      <td>ABI-008 Trial in Patients With Metastatic Brea...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>To determine the maximum tolerated dose (MTD) ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT00204230</td>\n",
       "      <td>MMF and Calcineurin Inhibitor Withdrawal in CAN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Prospective, randomised study: Effect of mycop...</td>\n",
       "      <td>Prospective, randomised study: Effect of mycop...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NCT04130438</td>\n",
       "      <td>Efficacy of Medical Therapy in Women and Men W...</td>\n",
       "      <td>Low recruitment, insufficient funding</td>\n",
       "      <td>Enrollment</td>\n",
       "      <td>The proposed clinical trial is relevant to pub...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NCT00386659</td>\n",
       "      <td>Immune Reconstitution in naïve HIV Patients Wi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Pilot, randomized, parallel, open-label, contr...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT02590003</td>\n",
       "      <td>Single Agent Versus Combination Chemotherapy t...</td>\n",
       "      <td>Trial was stopped after non-response to treatm...</td>\n",
       "      <td>Other/Unclear</td>\n",
       "      <td>This study will enroll elderly patients with a...</td>\n",
       "      <td>The primary objective of this trial is to comp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NCT04973137</td>\n",
       "      <td>A Study to Evaluate the Efficacy and Safety of...</td>\n",
       "      <td>The AFFIRM-AL clinical trial did not meet its ...</td>\n",
       "      <td>Efficacy</td>\n",
       "      <td>A Phase 3 study to evaluate the efficacy and s...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id                                        brief_title  \\\n",
       "0  NCT00025493  S0029 Docetaxel in Treating Older Women With M...   \n",
       "1  NCT00726986  Sorafenib, Cisplatin, and Etoposide in Treatin...   \n",
       "2  NCT04218825  REACH: Study to Determine the Aetiology of Chl...   \n",
       "3  NCT01548651  Effect of Saxagliptin Treatment on Myocardial ...   \n",
       "4  NCT00531271  ABI-008 Trial in Patients With Metastatic Brea...   \n",
       "5  NCT00204230    MMF and Calcineurin Inhibitor Withdrawal in CAN   \n",
       "6  NCT04130438  Efficacy of Medical Therapy in Women and Men W...   \n",
       "7  NCT00386659  Immune Reconstitution in naïve HIV Patients Wi...   \n",
       "8  NCT02590003  Single Agent Versus Combination Chemotherapy t...   \n",
       "9  NCT04973137  A Study to Evaluate the Efficacy and Safety of...   \n",
       "\n",
       "                                         why_stopped termination_category  \\\n",
       "0                                       poor accrual           Enrollment   \n",
       "1                                   Extreme toxicity               Safety   \n",
       "2  After an extensive assessment of the study fea...           Enrollment   \n",
       "3             difficulty with enrollment of subjects           Enrollment   \n",
       "4                                                NaN              Unknown   \n",
       "5                                                NaN              Unknown   \n",
       "6              Low recruitment, insufficient funding           Enrollment   \n",
       "7                                                NaN              Unknown   \n",
       "8  Trial was stopped after non-response to treatm...        Other/Unclear   \n",
       "9  The AFFIRM-AL clinical trial did not meet its ...             Efficacy   \n",
       "\n",
       "                                       brief_summary  \\\n",
       "0  RATIONALE: Drugs used in chemotherapy use diff...   \n",
       "1  RATIONALE: Sorafenib may stop the growth of tu...   \n",
       "2  Adult patients with early stage MF-CTCL (stage...   \n",
       "3  The purpose of the study is to examine the eff...   \n",
       "4  To determine the maximum tolerated dose (MTD) ...   \n",
       "5  Prospective, randomised study: Effect of mycop...   \n",
       "6  The proposed clinical trial is relevant to pub...   \n",
       "7  Pilot, randomized, parallel, open-label, contr...   \n",
       "8  This study will enroll elderly patients with a...   \n",
       "9  A Phase 3 study to evaluate the efficacy and s...   \n",
       "\n",
       "                                detailed_description  \n",
       "0                                                NaN  \n",
       "1                                                NaN  \n",
       "2                                                NaN  \n",
       "3                                                NaN  \n",
       "4                                                NaN  \n",
       "5  Prospective, randomised study: Effect of mycop...  \n",
       "6                                                NaN  \n",
       "7                                                NaN  \n",
       "8  The primary objective of this trial is to comp...  \n",
       "9                                                NaN  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#load the pilot dataset\n",
    "pilot_df = pd.read_csv('terminated_ground_truth.csv')\n",
    "pilot_df.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "90e5fda6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.int64(5309)"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#count how many termination_category as `Other/Unclear`\n",
    "pilot_df['termination_category'].value_counts()['Other/Unclear']\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "1b7a1dee",
   "metadata": {},
   "outputs": [],
   "source": [
    "unclear_df = pilot_df[pilot_df['termination_category'] == 'Other/Unclear']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "5b6604af",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>termination_category</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT02590003</td>\n",
       "      <td>Single Agent Versus Combination Chemotherapy t...</td>\n",
       "      <td>Trial was stopped after non-response to treatm...</td>\n",
       "      <td>Other/Unclear</td>\n",
       "      <td>This study will enroll elderly patients with a...</td>\n",
       "      <td>The primary objective of this trial is to comp...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>NCT01639664</td>\n",
       "      <td>COMPACT 2 - COMbining Plasma-filtration and Ad...</td>\n",
       "      <td>The interim analysis requested by the EDSMC sh...</td>\n",
       "      <td>Other/Unclear</td>\n",
       "      <td>The study objective is to clarify whether the ...</td>\n",
       "      <td>Septic shock is a life-threatening clinical co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>NCT02822482</td>\n",
       "      <td>Copanlisib in Association With Cetuximab in Pa...</td>\n",
       "      <td>futilty of the treatment</td>\n",
       "      <td>Other/Unclear</td>\n",
       "      <td>The study consists of two distinct and sequent...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>NCT01094262</td>\n",
       "      <td>A Safety and Tolerability Study of JNJ-4216044...</td>\n",
       "      <td>Logistic reasons associated with the FDA-impos...</td>\n",
       "      <td>Other/Unclear</td>\n",
       "      <td>The purpose of this study is to evaluate pain ...</td>\n",
       "      <td>This is a double-blind (neither the physician ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>NCT02259348</td>\n",
       "      <td>Repeat Transplantation for Relapsed or Refract...</td>\n",
       "      <td>Investigator's decision.</td>\n",
       "      <td>Other/Unclear</td>\n",
       "      <td>This pilot phase II trial studies how well a n...</td>\n",
       "      <td>PRIMARY OBJECTIVE:~* To estimate engraftment b...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         nct_id                                        brief_title  \\\n",
       "8   NCT02590003  Single Agent Versus Combination Chemotherapy t...   \n",
       "11  NCT01639664  COMPACT 2 - COMbining Plasma-filtration and Ad...   \n",
       "13  NCT02822482  Copanlisib in Association With Cetuximab in Pa...   \n",
       "16  NCT01094262  A Safety and Tolerability Study of JNJ-4216044...   \n",
       "18  NCT02259348  Repeat Transplantation for Relapsed or Refract...   \n",
       "\n",
       "                                          why_stopped termination_category  \\\n",
       "8   Trial was stopped after non-response to treatm...        Other/Unclear   \n",
       "11  The interim analysis requested by the EDSMC sh...        Other/Unclear   \n",
       "13                           futilty of the treatment        Other/Unclear   \n",
       "16  Logistic reasons associated with the FDA-impos...        Other/Unclear   \n",
       "18                           Investigator's decision.        Other/Unclear   \n",
       "\n",
       "                                        brief_summary  \\\n",
       "8   This study will enroll elderly patients with a...   \n",
       "11  The study objective is to clarify whether the ...   \n",
       "13  The study consists of two distinct and sequent...   \n",
       "16  The purpose of this study is to evaluate pain ...   \n",
       "18  This pilot phase II trial studies how well a n...   \n",
       "\n",
       "                                 detailed_description  \n",
       "8   The primary objective of this trial is to comp...  \n",
       "11  Septic shock is a life-threatening clinical co...  \n",
       "13                                                NaN  \n",
       "16  This is a double-blind (neither the physician ...  \n",
       "18  PRIMARY OBJECTIVE:~* To estimate engraftment b...  "
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unclear_df.head() "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "eabb78dd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>termination_category</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NCT02590003</td>\n",
       "      <td>Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer</td>\n",
       "      <td>Trial was stopped after non-response to treatment.</td>\n",
       "      <td>Other/Unclear</td>\n",
       "      <td>This study will enroll elderly patients with advanced non-small cell lung cancer who are at high risk of developing chemotherapy toxicity (side effects). Patients will receive treatment with either a platinum-based doublet chemotherapy with carboplatin/nab-paclitaxel or single agent nab-paclitaxel of chemotherapy. Response to treatment and treatment toxicity will be compared in the two treatment groups to determine the best treatment strategy for this group of patients.</td>\n",
       "      <td>The primary objective of this trial is to compare the treatment failure-free survival rate in high-risk elderly patients, identified by geriatric assessment, treated with either a platinum-based doublet chemotherapy with carboplatin/nab-paclitaxel or single agent nab-paclitaxel in advanced non-small cell lung cancer. Treatment failure-free survival is the most appropriate primary outcome as it captures excessive toxicity due to chemotherapy in addition to death and disease progression.~The secondary objectives are to evaluate grade 3-5 toxicities, overall response rate, progression free survival, symptom assessment, and overall survival between the two randomization arms.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id  \\\n",
       "8  NCT02590003   \n",
       "\n",
       "                                                                                               brief_title  \\\n",
       "8  Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer   \n",
       "\n",
       "                                          why_stopped termination_category  \\\n",
       "8  Trial was stopped after non-response to treatment.        Other/Unclear   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                brief_summary  \\\n",
       "8  This study will enroll elderly patients with advanced non-small cell lung cancer who are at high risk of developing chemotherapy toxicity (side effects). Patients will receive treatment with either a platinum-based doublet chemotherapy with carboplatin/nab-paclitaxel or single agent nab-paclitaxel of chemotherapy. Response to treatment and treatment toxicity will be compared in the two treatment groups to determine the best treatment strategy for this group of patients.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       detailed_description  \n",
       "8  The primary objective of this trial is to compare the treatment failure-free survival rate in high-risk elderly patients, identified by geriatric assessment, treated with either a platinum-based doublet chemotherapy with carboplatin/nab-paclitaxel or single agent nab-paclitaxel in advanced non-small cell lung cancer. Treatment failure-free survival is the most appropriate primary outcome as it captures excessive toxicity due to chemotherapy in addition to death and disease progression.~The secondary objectives are to evaluate grade 3-5 toxicities, overall response rate, progression free survival, symptom assessment, and overall survival between the two randomization arms.  "
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#select rows where nct_id is NCT02590003\n",
    "#Read the full rows without truncation\n",
    "\n",
    "unclear_df[unclear_df['nct_id'] == 'NCT02590003']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "de0c66f2",
   "metadata": {},
   "outputs": [],
   "source": [
    "DATA_DIR = r\"c:/Users/1234/OneDrive - Vanderbilt/Projects/LLM-clinical trials/CT_data_full/main_data\"\n",
    "\n",
    "import os\n",
    "from collections import Counter\n",
    "import re\n",
    "\n",
    "def analyze_full_pipeline():\n",
    "    print(\"Loading studies.txt...\")\n",
    "    studies = pd.read_csv(\n",
    "        os.path.join(DATA_DIR, \"studies.txt\"),\n",
    "        sep=\"|\",\n",
    "        usecols=[\"nct_id\", \"overall_status\", \"study_type\", \"why_stopped\"],\n",
    "        low_memory=False\n",
    "    )\n",
    "    total_studies = len(studies)\n",
    "    unique_ids = studies[\"nct_id\"].nunique()\n",
    "    print(f\"Total Studies in file: {total_studies}\")\n",
    "    print(f\"Unique NCT IDs: {unique_ids}\")\n",
    "    \n",
    "    print(\"Loading designs.txt...\")\n",
    "    designs = pd.read_csv(\n",
    "        os.path.join(DATA_DIR, \"designs.txt\"),\n",
    "        sep=\"|\",\n",
    "        usecols=[\"nct_id\", \"primary_purpose\"],\n",
    "        low_memory=False\n",
    "    )\n",
    "    \n",
    "    # Merge\n",
    "    df = studies.merge(designs, on=\"nct_id\", how=\"left\")\n",
    "    \n",
    "    # Step 1: Filter Interventional\n",
    "    interventional = df[df[\"study_type\"] == \"INTERVENTIONAL\"]\n",
    "    print(f\"Step 1 (Interventional): {len(interventional)}\")\n",
    "    \n",
    "    # Step 2: Filter Terminated\n",
    "    terminated = interventional[interventional[\"overall_status\"] == \"TERMINATED\"]\n",
    "    print(f\"Step 2 (Terminated): {len(terminated)}\")\n",
    "    \n",
    "    # Step 3: Filter Treatment\n",
    "    treatment = terminated[terminated[\"primary_purpose\"] == \"TREATMENT\"]\n",
    "    print(f\"Step 3 (Treatment): {len(treatment)}\")\n",
    "    \n",
    "    # Step 4: COVID Analysis\n",
    "    # Ensure why_stopped is string\n",
    "    treatment = treatment.copy()\n",
    "    treatment[\"why_stopped\"] = treatment[\"why_stopped\"].fillna(\"\").astype(str)\n",
    "    \n",
    "    covid_mask = treatment[\"why_stopped\"].str.contains(\"covid|coronavirus|pandemic|sars-cov-2\", case=False)\n",
    "    covid_count = covid_mask.sum()\n",
    "    print(f\"Step 4 (COVID Excluded): {covid_count}\")\n",
    "    \n",
    "    final_prospects = treatment[~covid_mask]\n",
    "    print(f\"Final Candidates for Ground Truth: {len(final_prospects)}\")\n",
    "    \n",
    "    # Text Analysis on Final Candidates\n",
    "    print(\"\\n--- Why Stopped Analysis (Final Candidates) ---\")\n",
    "    \n",
    "    final_prospects = treatment[~covid_mask]\n",
    "    print(f\"Final Candidates for Ground Truth: {len(final_prospects)}\")\n",
    "    return final_prospects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "48fcc4c4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading studies.txt...\n",
      "Total Studies in file: 557381\n",
      "Unique NCT IDs: 557381\n",
      "Loading designs.txt...\n",
      "Step 1 (Interventional): 425719\n",
      "Step 2 (Terminated): 28088\n",
      "Step 3 (Treatment): 21041\n",
      "Step 4 (COVID Excluded): 841\n",
      "Final Candidates for Ground Truth: 20200\n",
      "\n",
      "--- Why Stopped Analysis (Final Candidates) ---\n",
      "Final Candidates for Ground Truth: 20200\n"
     ]
    }
   ],
   "source": [
    "final_prospects = analyze_full_pipeline()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "4a90c343",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Why Stopped Analysis (Final Candidates) ---\n",
      "\n",
      "Top 20 Exact Reasons:\n",
      "why_stopped\n",
      "                                                   2321\n",
      "Slow accrual                                        178\n",
      "Sponsor decision                                    171\n",
      "Low accrual                                         106\n",
      "See termination reason in detailed description.      96\n",
      "slow accrual                                         96\n",
      "Sponsor Decision                                     96\n",
      "low accrual                                          93\n",
      "Lack of enrollment                                   89\n",
      "Slow enrollment                                      75\n",
      "Poor accrual                                         74\n",
      "Business decision                                    72\n",
      "Lack of efficacy                                     70\n",
      "Slow recruitment                                     69\n",
      "Low enrollment                                       69\n",
      "Slow Accrual                                         64\n",
      "Lack of funding                                      57\n",
      "Poor recruitment                                     56\n",
      "Administratively complete.                           50\n",
      "Futility                                             47\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Top 20 Common Words (Filtered):\n",
      "[('terminated', 2427), ('enrollment', 2105), ('recruitment', 2086), ('decision', 1909), ('accrual', 1808), ('sponsor', 1722), ('slow', 1536), ('lack', 1487), ('low', 1341), ('safety', 1302), ('patients', 1154), ('funding', 923), ('efficacy', 904), ('trial', 903), ('business', 801), ('early', 783), ('analysis', 753), ('stopped', 730), ('data', 703), ('poor', 652)]\n"
     ]
    }
   ],
   "source": [
    "# Text Analysis on Final Candidates\n",
    "print(\"\\n--- Why Stopped Analysis (Final Candidates) ---\")\n",
    "\n",
    "# Top 20 Exact Reasons\n",
    "print(\"\\nTop 20 Exact Reasons:\")\n",
    "print(final_prospects[\"why_stopped\"].value_counts().head(20))\n",
    "# Top 20 Words\n",
    "text = \" \".join(final_prospects[\"why_stopped\"].tolist()).lower()\n",
    "# Simple tokenization\n",
    "words = re.findall(r'\\b[a-z]{3,}\\b', text) # Ignore short words\n",
    "stop_words = {'the', 'was', 'and', 'for', 'due', 'not', 'study', 'with', 'this', 'were', 'from', 'that', 'are', 'have', 'been'} \n",
    "filtered_words = [w for w in words if w not in stop_words]\n",
    "\n",
    "common_words = Counter(filtered_words).most_common(20)\n",
    "print(\"\\nTop 20 Common Words (Filtered):\")\n",
    "print(common_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "7fa52d58",
   "metadata": {},
   "outputs": [],
   "source": [
    "#read pilot ground truth\n",
    "pilot_df = pd.read_csv(r\"c:/Users/1234/OneDrive - Vanderbilt/Projects/LLM-clinical trials/pilot_ground_truth_with_fields.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "e57e937b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>brief_summary</th>\n",
       "      <th>detailed_description</th>\n",
       "      <th>medical_field</th>\n",
       "      <th>medical_subfield</th>\n",
       "      <th>field_source</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT04566133</td>\n",
       "      <td>Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).</td>\n",
       "      <td>Slow accrual</td>\n",
       "      <td>Background:~Bile duct cancer is cancer of the slender tubes of the biliary tract. These tubes carry bile through the liver. Such cancer tumors often have an abnormal or mutated gene. Researchers t...</td>\n",
       "      <td>Background:~* Among the new cases of bile tract carcinoma (BTC) that are diagnosed every year in the United States, there are approximately 6,500 cases of gallbladder carcinoma, 3,000 cases of ext...</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>Other cancer</td>\n",
       "      <td>MeSH</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02815488</td>\n",
       "      <td>A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD</td>\n",
       "      <td>Very poor recruitment in the Part 4 of the study</td>\n",
       "      <td>CHF6297 is a potent and selective inhibitor of human MAP kinase p38 being developed as an anti-inflammatory agent for the treatment of inflammatory airways diseases. The purpose of this study is t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pulmonology</td>\n",
       "      <td>Pulmonology disorder</td>\n",
       "      <td>MeSH</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02721888</td>\n",
       "      <td>Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism</td>\n",
       "      <td>Failure of inclusion</td>\n",
       "      <td>Non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, metabolic syndrome and type 2 diabetes. NAFLD, in patients with type 2 diabetes, has been shown to be associated with...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Endocrinology</td>\n",
       "      <td>Endocrinology disorder</td>\n",
       "      <td>MeSH</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT01760304</td>\n",
       "      <td>Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo</td>\n",
       "      <td>Sponsor decided to stop the study due to expiration of blinded placebo .</td>\n",
       "      <td>To investigate whether Budesonide/Formoterol (Symbicort ®) therapy can improve heart function at rest by decreasing lung hyperinflation in patients with COPD (Chronic Obstructive Pulmonary Disease).</td>\n",
       "      <td>Patients with moderate to advanced COPD are known to have static hyperinflation (at rest) as a consequence of expiratory flow limitation. Hyperinflation is easily detected by measuring lung volume...</td>\n",
       "      <td>Pulmonology</td>\n",
       "      <td>Pulmonology disorder</td>\n",
       "      <td>MeSH</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00799942</td>\n",
       "      <td>Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The purpose of this study is to investigate the long-term safety, tolerability and efficacy of neramexane mesylate in the treatment of congenital idiopathic nystagmus (CIN). In addition, a subgrou...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ophthalmology</td>\n",
       "      <td>Ophthalmology disorder</td>\n",
       "      <td>MeSH</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id  \\\n",
       "0  NCT04566133   \n",
       "1  NCT02815488   \n",
       "2  NCT02721888   \n",
       "3  NCT01760304   \n",
       "4  NCT00799942   \n",
       "\n",
       "                                                                                                                                                           brief_title  \\\n",
       "0   Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).   \n",
       "1  A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD   \n",
       "2                                                                                              Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism   \n",
       "3                                               Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo   \n",
       "4                                                           Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus   \n",
       "\n",
       "                                                                why_stopped  \\\n",
       "0                                                              Slow accrual   \n",
       "1                          Very poor recruitment in the Part 4 of the study   \n",
       "2                                                      Failure of inclusion   \n",
       "3  Sponsor decided to stop the study due to expiration of blinded placebo .   \n",
       "4                                                                       NaN   \n",
       "\n",
       "                                                                                                                                                                                             brief_summary  \\\n",
       "0  Background:~Bile duct cancer is cancer of the slender tubes of the biliary tract. These tubes carry bile through the liver. Such cancer tumors often have an abnormal or mutated gene. Researchers t...   \n",
       "1  CHF6297 is a potent and selective inhibitor of human MAP kinase p38 being developed as an anti-inflammatory agent for the treatment of inflammatory airways diseases. The purpose of this study is t...   \n",
       "2  Non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, metabolic syndrome and type 2 diabetes. NAFLD, in patients with type 2 diabetes, has been shown to be associated with...   \n",
       "3   To investigate whether Budesonide/Formoterol (Symbicort ®) therapy can improve heart function at rest by decreasing lung hyperinflation in patients with COPD (Chronic Obstructive Pulmonary Disease).   \n",
       "4  The purpose of this study is to investigate the long-term safety, tolerability and efficacy of neramexane mesylate in the treatment of congenital idiopathic nystagmus (CIN). In addition, a subgrou...   \n",
       "\n",
       "                                                                                                                                                                                      detailed_description  \\\n",
       "0  Background:~* Among the new cases of bile tract carcinoma (BTC) that are diagnosed every year in the United States, there are approximately 6,500 cases of gallbladder carcinoma, 3,000 cases of ext...   \n",
       "1                                                                                                                                                                                                      NaN   \n",
       "2                                                                                                                                                                                                      NaN   \n",
       "3  Patients with moderate to advanced COPD are known to have static hyperinflation (at rest) as a consequence of expiratory flow limitation. Hyperinflation is easily detected by measuring lung volume...   \n",
       "4                                                                                                                                                                                                      NaN   \n",
       "\n",
       "   medical_field        medical_subfield field_source  \n",
       "0       Oncology            Other cancer         MeSH  \n",
       "1    Pulmonology    Pulmonology disorder         MeSH  \n",
       "2  Endocrinology  Endocrinology disorder         MeSH  \n",
       "3    Pulmonology    Pulmonology disorder         MeSH  \n",
       "4  Ophthalmology  Ophthalmology disorder         MeSH  "
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_colwidth', 200)\n",
    "pilot_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3b9d98ef",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
